|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
13
|
|
pubmed:dateCreated |
1999-10-27
|
|
pubmed:abstractText |
In an intent-to-treat study increase in CD4 cell count, reduction of viral load, clinical benefit and adverse reactions were examined in HIV-infected previously treatment-naive children taking triple therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0269-9370
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
10
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1653-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10509566-Anti-HIV Agents,
pubmed-meshheading:10509566-CD4 Lymphocyte Count,
pubmed-meshheading:10509566-Child,
pubmed-meshheading:10509566-Child, Preschool,
pubmed-meshheading:10509566-Didanosine,
pubmed-meshheading:10509566-Drug Therapy, Combination,
pubmed-meshheading:10509566-Female,
pubmed-meshheading:10509566-HIV Infections,
pubmed-meshheading:10509566-Humans,
pubmed-meshheading:10509566-Infant,
pubmed-meshheading:10509566-Lamivudine,
pubmed-meshheading:10509566-Male,
pubmed-meshheading:10509566-Nelfinavir,
pubmed-meshheading:10509566-Prospective Studies,
pubmed-meshheading:10509566-Reverse Transcriptase Inhibitors,
pubmed-meshheading:10509566-Stavudine,
pubmed-meshheading:10509566-Viral Load,
pubmed-meshheading:10509566-Zidovudine
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children.
|
|
pubmed:affiliation |
Children's Hospital, Johann Wolfgang Goethe-University Frankfurt, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
